IRIS
PILOTTO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.749
AS - Asia 3.139
EU - Europa 1.422
SA - Sud America 439
AF - Africa 151
Continente sconosciuto - Info sul continente non disponibili 82
OC - Oceania 6
Totale 8.988
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.637
SG - Singapore 1.111
CN - Cina 973
VN - Vietnam 393
SE - Svezia 377
IE - Irlanda 360
BR - Brasile 353
HK - Hong Kong 187
TR - Turchia 160
IT - Italia 116
FR - Francia 111
BD - Bangladesh 105
ZA - Sudafrica 90
NL - Olanda 88
DE - Germania 84
CA - Canada 69
FI - Finlandia 59
GB - Regno Unito 56
RU - Federazione Russa 49
IN - India 41
AR - Argentina 28
CI - Costa d'Avorio 24
IQ - Iraq 21
MX - Messico 21
PL - Polonia 19
ES - Italia 17
UA - Ucraina 17
BE - Belgio 15
CO - Colombia 15
PH - Filippine 15
IR - Iran 13
JP - Giappone 13
PK - Pakistan 13
UZ - Uzbekistan 13
MA - Marocco 11
MY - Malesia 11
VE - Venezuela 11
EC - Ecuador 9
TH - Thailandia 9
AZ - Azerbaigian 8
PY - Paraguay 7
AT - Austria 6
CL - Cile 6
CR - Costa Rica 6
ID - Indonesia 6
KR - Corea 6
AU - Australia 5
KE - Kenya 5
SA - Arabia Saudita 5
TN - Tunisia 5
BG - Bulgaria 4
CH - Svizzera 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
LT - Lituania 4
LV - Lettonia 4
LY - Libia 4
PE - Perù 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EU - Europa 3
JO - Giordania 3
KG - Kirghizistan 3
KH - Cambogia 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
LB - Libano 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SR - Suriname 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CV - Capo Verde 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
FJ - Figi 1
GE - Georgia 1
GR - Grecia 1
Totale 8.900
Salva come PNG Salva come JPEG
Città #
Chandler 580
Singapore 539
Ashburn 533
Santa Clara 386
Dublin 360
San Jose 292
Beijing 242
Hong Kong 179
Ho Chi Minh City 132
Nanjing 129
Izmir 125
Dearborn 114
Dallas 97
Boardman 96
Council Bluffs 93
Johannesburg 89
Hanoi 83
Los Angeles 81
New York 75
Princeton 74
Lauterbourg 67
Shanghai 64
Helsinki 43
Moscow 42
Munich 42
Wilmington 42
Shenyang 41
Nanchang 39
São Paulo 36
Kunming 34
Columbus 32
Jiaxing 30
Toronto 28
Hebei 26
Buffalo 25
Guangzhou 25
San Mateo 23
Abidjan 22
Tianjin 21
Da Nang 20
Frankfurt am Main 19
Jinan 19
Kocaeli 19
Changsha 18
Rome 18
The Dalles 18
London 17
Milan 16
Montreal 16
Turku 16
Hefei 15
Seattle 15
Haiphong 14
Phoenix 14
Ann Arbor 13
Brussels 13
Hangzhou 13
Rio de Janeiro 13
Fremont 12
Norwalk 12
Orem 12
Zhengzhou 12
Atlanta 11
Baghdad 11
Denver 11
Pune 11
Tashkent 11
Tokyo 11
Warsaw 11
Jacksonville 10
Parma 10
Kuala Lumpur 9
Naples 9
Boston 8
Philadelphia 8
San Francisco 8
Baku 7
Leawood 7
Ningbo 7
Stockholm 7
Bangkok 6
Brasília 6
Can Tho 6
Washington 6
Amsterdam 5
Cambridge 5
Changchun 5
Chicago 5
Fortaleza 5
Houston 5
Hải Dương 5
Istanbul 5
Mexico City 5
Newark 5
Tây Ninh 5
Zanjan 5
Bratislava 4
Bình Phước 4
Caracas 4
Chengdu 4
Totale 5.602
Salva come PNG Salva come JPEG
Nome #
H2-blockers in the treatment of ulcer disease in the elderly 194
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 172
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 169
Current concepts in the management of helicobacter pylori infection: The maastricht III consensus report 168
Acid-related disorders in the elderly 163
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 160
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 156
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 154
ASSESSMENT OF SYMPTOMS IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD) 154
Efficacy of 5-ASA in the treatment of colonic diverticular disease 154
A comparison of five maintenance therapies for reflux esophagitis 153
TERAPIA DI MANTENIMENTO PER UN ANNO CON ANTI-H2 NELL'ULCERA PEPTICA DELL'ANZIANO: IMPORTANZA DELLA SINTOMATOLOGIA COME MARKER DI RECIDIVA 153
ASPETTI METODOLOGICI DEL SONDAGGIO GASTRICO 148
M1261 Recurrence of Diverticulitis in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) Treated Cyclically With Mesalamine: Result of a Follow-up Study 148
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 147
PPIs plus H2-antagonists for non-responders GERD patients: A rescue therapy? (a three months pilot study) 144
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 144
Chronic atrophic gastritis (CAG) and Helicobacter pylori infection eradication: A 3 years follow-up 143
Are morphology and composition of gallstones related? An x-ray diffraction study 143
W1235 Efficacy of 5-ASA in the Treatment of Colonic Diverticular Disease: A Systematic Review 142
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study) 142
Compliance with therapy for ulcer disease: clinical experience and review of the literature 142
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 142
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 142
M1260 Effect of Cyclically Long-Term Treatment With Mesalamine in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD): A 5 Years Follow-up Study 141
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 139
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 136
M1262 Baseline Symptoms in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) 136
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 135
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 133
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 133
The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people 129
Cytotoxin-Associated Gene A-Positive Helicobacter pylori infection in the Elderly: Association with gastric atrophy and intestinal metaplasia 129
Clarithromycin for the cure of Helicobacter pylori infection: One or two weeks of treatment 127
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 122
Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly. A case-control study 120
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 120
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 120
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 119
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 119
La terapia delle malattie acido-correlate nell'anziano 117
ACIDO N-ACETILNEURAMINICO DOPO PENTAGASTRINA E SECRETINA IN SOGGETTI CON ULCERA DUODENALE E DISPEPSIA NON ULCEROSA 117
One-week H. Pylori eradication therapy Rabeprezole 20 mg bid vs 10 mg bid 115
The cure for Helicobacter pylori ((HP) infection with double or triple omeprazole-based therápies in the elderly: Effects on eradication rate, chronic gastritis and serum anti-HP antibodies and pepsinogens 115
The outcome of low and high grade of chronic atrofic gastritis (CAG) after Helicobacter pylori infection eradication: a 3 years follow-up 114
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? 113
Rhythm changes of the heart during upper gastrointestinal endoscopy in the elderly 113
Changes in parietal and mucous cell mass in the gastric mucosa of normal subjects with age: A morphometric study 112
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study 106
Markers of slow-healing peptic ulcer in the elderly - A study on 1,052 ranitidine-treated patients 104
Antagonism to calcium antagonists [1] 104
Treatment options for Helicobacter pylori infection in the elderly 102
Tauroursodeoxycholic acid in the treatment of biliary dyspepsia 101
Sucralfate and cisapride in the treatment of duodenogastric reflux and dyspepsia: A randomized study 100
Do concomitant diseases and therapies affect the persistence of ulcer symptoms in the elderly? 100
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study 97
Epidemiology of helicobacter pylori resistance to antffiiotics in North East of Italy: A multicenter study 95
Sucralfate gel versus ranitidine in the treatment of gastroesophageal reflux disease: A controlled study 93
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 91
GERD with oropharingeal picture: A prospective therapeutical one-year study 90
Prevalence of H. pylori resistance to antibiotics in North-East Italy: A multicentered study 90
The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease 90
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study 89
P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS 89
Role of proton pump inhibitors in the prevention of upper GI bleeding in elderly acute and chronic NSAID users 89
Long-term clinical outcome of elderly patients with esophagitis: A three year follow-up study 86
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly 86
Reply 84
Digestive Diseases: Editorial 84
Response to kittisupamongkol 81
Low-doses versus standard-doses of clarithromycin in combination with amoxycillin and rabeprazole for the eradication of H. pylori infection in elderly subjects 79
The long-term clinical outcome of elderly patients with Helicobacter pylori-associated peptic ulcer disease 72
Drug use and upper gastrointestinal tract in the elderly: An epidemiological survey of general practitioners 70
LA TERAPIA DELLA MALATTIA ULCEROSA NELL'ANZIANO: STUDIO PROSPETTICO RANDOMIZZATO CON FARMACI ANTISECRETORI 55
null 10
Totale 8.988
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.482
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022339 0 0 0 24 31 1 4 35 16 26 43 159
2022/20231.549 151 172 130 145 97 195 8 121 452 6 61 11
2023/2024445 23 49 13 8 37 110 28 40 24 27 44 42
2024/20251.845 38 88 90 79 256 263 81 91 254 156 147 302
2025/20263.185 343 276 306 246 496 209 340 83 372 258 153 103
2026/2027545 78 161 172 134 0 0 0 0 0 0 0 0
Totale 8.988